PROM1 and neoplasm: constructed CD133-specific CAR-T cells (CD133 CAR-T) and found that CD133 CAR-T displayed distinctive lysis activity and secreted high level of cytokines targeting CD133+ cells and remarkably suppressed tumor growth in vivo.